Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy

BACKGROUND: Natalizumab is an effective treatment for relapsing multiple sclerosis. Return of disease activity upon natalizumab discontinuance creates the need for follow-up therapeutic strategies. OBJECTIVE: To assess the efficacy of teriflunomide following natalizumab discontinuance in relapsing m...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mult Scler J Exp Transl Clin
Главные авторы: Cohan, Stanley L, Edwards, Keith, Lucas, Lindsay, Gervasi-Follmar, Tiffany, O’Connor, Judy, Siuta, Jessica, Kamath, Vineetha, Garten, Lore, Chen, Chiayi, Thomas, James, Smoot, Kyle, Kresa-Reahl, Kiren, Spinelli, Kateri J
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Original Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350141/
https://ncbi.nlm.nih.gov/pubmed/30729028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318824618
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы